0001104659-24-076423.txt : 20240628 0001104659-24-076423.hdr.sgml : 20240628 20240628181246 ACCESSION NUMBER: 0001104659-24-076423 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240619 FILED AS OF DATE: 20240628 DATE AS OF CHANGE: 20240628 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kyme Pierre CENTRAL INDEX KEY: 0002028892 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37544 FILM NUMBER: 241087283 MAIL ADDRESS: STREET 1: 5005 MCCONNELL AVENUE CITY: LOS ANGELES STATE: CA ZIP: 90066 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Armata Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0000921114 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 911549568 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5005 MCCONNELL AVE CITY: LOS ANGELES STATE: CA ZIP: 90066 BUSINESS PHONE: 310-665-2928 MAIL ADDRESS: STREET 1: 5005 MCCONNELL AVE CITY: LOS ANGELES STATE: CA ZIP: 90066 FORMER COMPANY: FORMER CONFORMED NAME: AmpliPhi Biosciences Corp DATE OF NAME CHANGE: 20130222 FORMER COMPANY: FORMER CONFORMED NAME: TARGETED GENETICS CORP /WA/ DATE OF NAME CHANGE: 19940331 3 1 tm2418494-1_3seq1.xml OWNERSHIP DOCUMENT X0206 3 2024-06-19 0 0000921114 Armata Pharmaceuticals, Inc. ARMP 0002028892 Kyme Pierre 5005 MCCONNELL AVENUE LOS ANGELES CA 90066 0 1 0 0 Chief Business Officer Common Stock 10000 D Stock Options (Right to Buy) 3.38 2034-03-14 Common Stock 40000 D Twenty-five percent (25%) of the Stock Options shall vest on March 14th of each of 2025, 2026, 2027, and 2028. /s/ Pierre Kyme 2024-06-28